Cargando…
Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients
BACKGROUND: Elderly patients with chronic kidney disease (CKD) are usually at a high risk of fractures due to both osteoporosis and CKD-mineral bone disease (MBD). A new marker is needed to prevent fractures and control CKD-MBD from the early to advanced stages of CKD. In the early stage of CKD, fib...
Autores principales: | Kanda, Eiichiro, Yoshida, Masayuki, Sasaki, Sei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506497/ https://www.ncbi.nlm.nih.gov/pubmed/23013306 http://dx.doi.org/10.1186/1471-2369-13-122 |
Ejemplares similares
-
High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients
por: Kanda, Eiichiro, et al.
Publicado: (2013) -
Relationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease
por: Nitta, Kosaku
Publicado: (2010) -
Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho
por: Kanda, Eiichiro, et al.
Publicado: (2016) -
UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE
por: Wolf, Myles
Publicado: (2012) -
Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice
por: Andrukhova, Olena, et al.
Publicado: (2018)